RxDB
ICD-10-CM Codes Browse (Tabular) Diagnostic External Drug Neoplasm

Z51.12 – Encounter for antineoplastic immunotherapy

Overview

Coding Notes

Active
Billable, valid for HIPAA-covered transactions

GEM Conversion to ICD-9 CM

Fs: 00000 – Encounter for antineoplastic immunotherapy

MDC / MS-DRG Reference

MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH MCC
MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITH CC
MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH MAJOR O.R. PROCEDURES WITHOUT CC/MCC
MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITH CC/MCC
MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASMS WITH OTHER PROCEDURES WITHOUT CC/MCC
CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC
CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT
CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC
CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC
CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC
CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC

Back Reference of Diagnostic Codes

Encounter (with health service) (for) Z76.89
immunotherapy for neoplasm Z51.12
Immunotherapy (encounter for)
antineoplastic Z51.12

Sibling Codes

Encounter for antineoplastic chemotherapy

Parent Sibling Codes

Encounter for antineoplastic radiation therapy
Encounter for antineoplastic chemotherapy and immunotherapy
Encounter for palliative care
Encounter for desensitization to allergens
Encounter for other specified aftercare

View in Tabular

Code Title
Z00-Z99 Factors influencing health status and contact with health services (Z00-Z99)
Z40-Z53 Encounters for other specific health care (Z40-Z53)
Z51 Encounter for other aftercare and medical care
Z51.1 Encounter for antineoplastic chemotherapy and immunotherapy
Z51.12 Encounter for antineoplastic immunotherapy